Oncology Drugs Market Research Report, Growth & Forecast

Publications found: 1,234

Sort by:

Thyroid Cancer Therapeutics Market Size, Share and Growth Outlook 2026: By Cancer Type, By Therapy Modality, By Route of Administration, By End-User, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Thyroid Cancer Therapeutics Market size is forecast to increase from $1026.69 Million in 2026 to $3206.81 Million in 2034 at a CAGR of 15.3% between 2026 and 2034. The Thyroid Cancer Therap...

July 2026 190 pages

Tumor Ablation Market Size, Share and Growth Outlook 2026: By Technology, By Treatment Mode, By Application, By End User, Companies to 2034

US$ 3,482.00

The global Tumor Ablation Market size is forecast to increase from $2.5 Billion in 2026 to $7.39 Billion in 2034 at a CAGR of 14.5% between 2026 and 2034. The Tumor Ablation market report provides det...

July 2026 190 pages

Tumor Tracking Systems Market Size, Share and Growth Outlook 2026: By Product and System Type, By Technology, By Application, By End-User, Companies to 2034

US$ 3,482.00

The global Tumor Tracking Systems Market size is forecast to increase from $4.9 Billion in 2026 to $7.16 Billion in 2034 at a CAGR of 4.85% between 2026 and 2034. The Tumor Tracking Systems market rep...

July 2026 190 pages

Tyrosine Kinase Inhibitors Market Size, Share and Growth Outlook 2026: By Target Receptor, By Application, By Generation, By Route of Administration, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Tyrosine Kinase Inhibitors Market size is forecast to increase from $66.29 Billion in 2026 to $124.53 Billion in 2034 at a CAGR of 8.2% between 2026 and 2034. The Tyrosine Kinase Inhibitors...

July 2026 190 pages

Unresectable Hepatocellular Carcinoma Market Size, Share and Growth Outlook 2026: By Treatment, By End User, By Treatment Stage, By Route of Administration, Companies to 2034

US$ 3,482.00

The global Unresectable Hepatocellular Carcinoma Market size is forecast to increase from $2.58 Billion in 2026 to $4.81 Billion in 2034 at a CAGR of 8.1% between 2026 and 2034. The Unresectable Hepat...

July 2026 190 pages

Kidney Cancer Drugs Market Size, Share and Growth Outlook 2026: By Therapy Type, By Pharmacological Class, By Cancer Type, By Route of Administration, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Kidney Cancer Drugs Market size is forecast to increase from $7.35 Billion in 2026 to $12.44 Billion in 2034 at a CAGR of 6.8% between 2026 and 2034. The Kidney Cancer Drugs market report p...

July 2026 190 pages

Lenalidomide Market Size, Share and Growth Outlook 2026: By Indication, By Dosage Strength, By Formulation Type, By Patient Age Group, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Lenalidomide Market size is forecast to increase from $15.57 Billion in 2026 to $23.88 Billion in 2034 at a CAGR of 5.49% between 2026 and 2034. The Lenalidomide market report provides deta...

July 2026 190 pages

Liposomal Doxorubicin Market Size, Share and Growth Outlook 2026: By Drug Type (Branded, Generic), By Application, By Distribution Channel, Companies to 2034.

US$ 3,482.00

The global Liposomal Doxorubicin Market size is forecast to increase from $1.52 Billion in 2026 to $2.68 Billion in 2034 at a CAGR of 7.36% between 2026 and 2034. The Liposomal Doxorubicin market repo...

July 2026 190 pages

Liver Cancer Drug Market Size, Share and Growth Outlook 2026: By Cancer Type, By Therapy Drug Class, By Mechanism of Action, By Route of Administration, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Liver Cancer Drug Market size is forecast to increase from $4.52 Billion in 2026 to $15.66 Billion in 2034 at a CAGR of 16.8% between 2026 and 2034. The Liver Cancer Drug market report prov...

July 2026 190 pages

Mammalian Cell Fermentation Technology Market Size, Share and Growth Outlook 2026: By Cell Line Type, By Application, By Technology, By Scale of Operation, By End-Use, Companies to 2034

US$ 3,482.00

The global Mammalian Cell Fermentation Technology Market size is forecast to increase from $53.45 Billion in 2026 to $101.9 Billion in 2034 at a CAGR of 8.4% between 2026 and 2034. The Mammalian Cell...

July 2026 190 pages

Manual Resuscitators Market Size, Share and Growth Outlook 2026: By Product Type (Self-Inflating Bags, Flow-Inflating Bags, T-Piece Resuscitators), By Usage, By Patient Type, By Material, By End User, Companies to 2034.

US$ 3,482.00

The global Manual Resuscitators Market size is forecast to increase from $650.96 Million in 2026 to $1061.26 Million in 2034 at a CAGR of 6.3% between 2026 and 2034. The Manual Resuscitators market re...

July 2026 190 pages

Myelodysplastic Syndrome Drugs Market Size, Share and Growth Outlook 2026: By Treatment Class, By Route of Administration, By Disease Subtype, By End Use, Companies to 2034

US$ 3,482.00

The global Myelodysplastic Syndrome Drugs Market size is forecast to increase from $3.77 Billion in 2026 to $7.64 Billion in 2034 at a CAGR of 9.23% between 2026 and 2034. The Myelodysplastic Syndrome...

July 2026 190 pages

Myeloproliferative Disorders Drugs Market Size, Share and Growth Outlook 2026: By Indication, By Treatment Type, By End Use, Companies to 2034

US$ 3,482.00

The global Myeloproliferative Disorders Drugs Market size is forecast to increase from $12.79 Billion in 2026 to $20.71 Billion in 2034 at a CAGR of 6.21% between 2026 and 2034. The Myeloproliferative...

July 2026 190 pages

Neuroendocrine Carcinoma Market Size, Share and Growth Outlook 2026: By Drug Class, By Indication, By Distribution Channel, By End User, Companies to 2034

US$ 3,482.00

The global Neuroendocrine Carcinoma Market size is forecast to increase from $1.69 Billion in 2026 to $2.84 Billion in 2034 at a CAGR of 6.72% between 2026 and 2034. The Neuroendocrine Carcinoma marke...

July 2026 190 pages

Oncology Devices Market Size, Share and Growth Outlook 2026: By Device Type, By Application, By Technology, By End User, Companies to 2034

US$ 3,482.00

The global Oncology Devices Market size is forecast to increase from $18.32 Billion in 2026 to $37.98 Billion in 2034 at a CAGR of 9.54% between 2026 and 2034. The Oncology Devices market report provi...

July 2026 190 pages

Oncolytic Virotherapy Market Size, Share and Growth Outlook 2026: By Product, By Application, By End User, Companies to 2034

US$ 3,482.00

The global Oncolytic Virotherapy Market size is forecast to increase from $42.48 Million in 2026 to $254.83 Million in 2034 at a CAGR of 25.1% between 2026 and 2034. The Oncolytic Virotherapy market r...

July 2026 190 pages

Ovarian Cancer Drugs Market Size, Share and Growth Outlook 2026: By Therapeutic Class, By Treatment Type, By End Use, Companies to 2034

US$ 3,482.00

The global Ovarian Cancer Drugs Market size is forecast to increase from $2.86 Billion in 2026 to $5.4 Billion in 2034 at a CAGR of 8.26% between 2026 and 2034. The Ovarian Cancer Drugs market report...

July 2026 190 pages

Precision Oncology Market Size, Share and Growth Outlook 2026: By Type (Therapeutics, Diagnostics), By Biomarker Type, By Cancer Type, By End-User, Companies to 2034.

US$ 3,482.00

The global Precision Oncology Market size is forecast to increase from $128.61 Billion in 2026 to $247.74 Billion in 2034 at a CAGR of 8.54% between 2026 and 2034. The Precision Oncology market report...

July 2026 190 pages

Radiation Oncology Market Size, Share and Growth Outlook 2026: By Therapy Type, By Technology, By Application, By End-User, Companies to 2034

US$ 3,482.00

The global Radiation Oncology Market size is forecast to increase from $16.95 Billion in 2026 to $41.58 Billion in 2034 at a CAGR of 11.87% between 2026 and 2034. The Radiation Oncology market report...

July 2026 190 pages

Radiodermatitis Market Size, Share and Growth Outlook 2026: By Product Type (Topical Therapies, Oral Drugs, Dressings, Medical Devices and Others), By Class of Radiodermatitis, By Distribution Channel, By End-User, Companies to 2034.

US$ 3,482.00

The global Radiodermatitis Market size is forecast to increase from $564.87 Million in 2026 to $792.3 Million in 2034 at a CAGR of 4.32% between 2026 and 2034. The Radiodermatitis market report provid...

July 2026 190 pages

Radiopharmaceuticals Market Size, Share and Growth Outlook 2026: By Type (Diagnostic Radiopharmaceuticals, Therapeutic Radiopharmaceuticals), By Radionuclide Type, By Application, By End-User, Companies to 2034.

US$ 3,482.00

The global Radiopharmaceuticals Market size is forecast to increase from $10.13 Billion in 2026 to $22.16 Billion in 2034 at a CAGR of 10.28% between 2026 and 2034. The Radiopharmaceuticals market rep...

July 2026 190 pages

Radiotheranostics Market Size, Share and Growth Outlook 2026: By Radioisotope (Lutetium-177, Actinium-225, Yttrium-90, Iodine-131, Others), By Source, By Approach, By Application, By End User, Companies to 2034.

US$ 3,482.00

The global Radiotheranostics Market size is forecast to increase from $14.65 Billion in 2026 to $30.1 Billion in 2034 at a CAGR of 9.42% between 2026 and 2034. The Radiotheranostics market report prov...

July 2026 190 pages

Sarcoma Drugs Market Size, Share and Growth Outlook 2026: By Treatment Type, By Disease Indication, By Drug Type, By Route of Administration, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Sarcoma Drugs Market size is forecast to increase from $1.82 Billion in 2026 to $3.54 Billion in 2034 at a CAGR of 8.67% between 2026 and 2034. The Sarcoma Drugs market report provides deta...

July 2026 190 pages

Small Bone and Joint Devices Market Size, Share and Growth Outlook 2026: By Product Type, By Application, By End User, Companies to 2034

US$ 3,482.00

The global Small Bone and Joint Devices Market size is forecast to increase from $5.67 Billion in 2026 to $9.15 Billion in 2034 at a CAGR of 6.16% between 2026 and 2034. The Small Bone and Joint Devic...

July 2026 190 pages

Small Molecule API Market Size, Share and Growth Outlook 2026: By Type (Synthetic / Chemical API, Biotech API), By Manufacturing Method, By Stage Type, By Application, By Customer Type, Companies to 2034.

US$ 3,482.00

The global Small Molecule API Market size is forecast to increase from $231.41 Billion in 2026 to $362.75 Billion in 2034 at a CAGR of 5.78% between 2026 and 2034. The Small Molecule API market report...

July 2026 190 pages

Stomach Cancer Treatment Market Size, Share and Growth Outlook 2026: By Treatment Type, By Drug Class, By Disease Indication, By Route of Administration, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Stomach Cancer Treatment Market size is forecast to increase from $7.1 Billion in 2026 to $18.35 Billion in 2034 at a CAGR of 12.6% between 2026 and 2034. The Stomach Cancer Treatment marke...

July 2026 190 pages

Urothelial Cancer Drugs Market Size, Share and Growth Outlook 2026: By Treatment Class, By Line of Therapy, By Cancer Stage, By Biomarker Status, By End User, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Urothelial Cancer Drugs Market size is forecast to increase from $4.28 Billion in 2026 to $9.79 Billion in 2034 at a CAGR of 10.89% between 2026 and 2034. The Urothelial Cancer Drugs market...

July 2026 190 pages

Insulinoma Treatment Market Size, Share and Growth Outlook 2026: By Diagnosis Method (Blood Tests, Imaging Tests, Endoscopic Ultrasound, Others), By Treatment Type, By End-User, Companies to 2034

US$ 3,482.00

The global Insulinoma Treatment Market size is forecast to increase from $3.92 Billion in 2026 to $5.08 Billion in 2034 at a CAGR of 3.3% between 2026 and 2034. The Insulinoma Treatment market report...

July 2026 190 pages

Laryngeal Cancer Therapeutics Market Size, Share and Growth Outlook 2026: By Product Type, By Treatment Type, By Molecule Type, By Dosage Form, By Route of Administration, By End-Use, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Laryngeal Cancer Therapeutics Market size is forecast to increase from $3.21 Billion in 2026 to $4.26 Billion in 2034 at a CAGR of 3.6% between 2026 and 2034. The Laryngeal Cancer Therapeut...

July 2026 190 pages

Lymphopenia Therapeutics Market Size, Share and Growth Outlook 2026: By Treatment (Stem Cell Therapy, Drug Therapy, Immune Globulin, Others), By Route of Administration, By End-User, By Distribution Channel, Companies to 2034.

US$ 3,482.00

The global Lymphopenia Therapeutics Market size is forecast to increase from $2.39 Billion in 2026 to $3.32 Billion in 2034 at a CAGR of 4.2% between 2026 and 2034. The Lymphopenia Therapeutics market...

July 2026 190 pages

Malignant Mesothelioma Therapeutics Market Size, Share and Growth Outlook 2026: By Therapeutic Class, By Cancer Type, By Pipeline Stage, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Malignant Mesothelioma Therapeutics Market size is forecast to increase from $6.99 Billion in 2026 to $11.31 Billion in 2034 at a CAGR of 6.2% between 2026 and 2034. The Malignant Mesotheli...

July 2026 190 pages

Medical Decision Support Systems Market Size, Share and Growth Outlook 2026: By System Type, By Model of Delivery, By Application, By Component, By End-User, Companies to 2034

US$ 3,482.00

The global Medical Decision Support Systems Market size is forecast to increase from $6.92 Billion in 2026 to $15.27 Billion in 2034 at a CAGR of 10.4% between 2026 and 2034. The Medical Decision Supp...

July 2026 190 pages

MEK Inhibitors Market Size, Share and Growth Outlook 2026: By Target (MEK1, MEK2), By Type, By Application, By Route of Administration, By Dosage, By Distribution Channel, By End User, Companies to 2034.

US$ 3,482.00

The global MEK Inhibitors Market size is forecast to increase from $1.16 Billion in 2026 to $1.86 Billion in 2034 at a CAGR of 6.1% between 2026 and 2034. The MEK Inhibitors market report provides det...

July 2026 190 pages

mTOR (Mammalian target of rapamycin) Inhibitors Market Size, Share and Growth Outlook 2026: By Drug Type, By Commercial Product Form, By Indication, By Route of Administration, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global mTOR (Mammalian target of rapamycin) Inhibitors Market size is forecast to increase from $7.86 Billion in 2026 to $10.43 Billion in 2034 at a CAGR of 3.6% between 2026 and 2034. The mTOR In...

July 2026 190 pages

Mycosis Fungoides Therapeutics Market Size, Share and Growth Outlook 2026: By Therapeutic Class, By Disease Stage Indication, By Route of Administration, By End-User Facility, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Mycosis Fungoides Therapeutics Market size is forecast to increase from $522.65 Million in 2026 to $682.93 Million in 2034 at a CAGR of 3.4% between 2026 and 2034. The Mycosis Fungoides The...

July 2026 190 pages

Neuroblastoma Drugs Market Size, Share and Growth Outlook 2026: By Product Type (Tablets, Vaccines, Injectable Drugs, Cell Therapy Products), By Treatment Type, By Distribution Channel, By End-User, Companies to 2034.

US$ 3,482.00

The global Neuroblastoma Drugs Market size is forecast to increase from $937.63 Million in 2026 to $1551.77 Million in 2034 at a CAGR of 6.5% between 2026 and 2034. The Neuroblastoma Drugs market repo...

July 2026 190 pages

Neutropenia Treatment Market Size, Share and Growth Outlook 2026: By Treatment, By Route of Administration, By Indication, By End User, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Neutropenia Treatment Market size is forecast to increase from $19.05 Billion in 2026 to $27.93 Billion in 2034 at a CAGR of 4.9% between 2026 and 2034. The Neutropenia Treatment market rep...

July 2026 190 pages

Non-melanoma Skin Cancer Market Size, Share and Growth Outlook 2026: By Indication (Basal Cell Carcinoma (BCC), Squamous Cell Carcinoma (SCC)), By Treatment, By End-User, Companies to 2034.

US$ 3,482.00

The global Non-melanoma Skin Cancer Market size is forecast to increase from $666.89 Million in 2026 to $926.82 Million in 2034 at a CAGR of 4.2% between 2026 and 2034. The Non-melanoma Skin Cancer ma...

July 2026 190 pages

Non-small Cell Lung Cancer Drugs Market Size, Share and Growth Outlook 2026: By Cancer Type (Adenocarcinoma, Squamous Cell Carcinoma, Large Cell Carcinoma), By Drug Class, By Disease Stage, By Distribution Channel, Companies to 2034.

US$ 3,482.00

The global Non-small Cell Lung Cancer Drugs Market size is forecast to increase from $27.25 Billion in 2026 to $66.51 Billion in 2034 at a CAGR of 11.8% between 2026 and 2034. The Non-small Cell Lung...

July 2026 190 pages

Oncology Drugs Market Size, Share and Growth Outlook 2026: By Therapy Type (Chemotherapy, Targeted Therapy, Hormonal Therapy, Others), By Modality, By Indication, By Route of Administration, By Distribution Channel, Companies to 2034.

US$ 3,482.00

The global Oncology Drugs Market size is forecast to increase from $191.39 Billion in 2026 to $343.89 Billion in 2034 at a CAGR of 7.6% between 2026 and 2034. The Oncology Drugs market report provides...

July 2026 190 pages

Oral Cancer Therapeutics Market Size, Share and Growth Outlook 2026: By Therapy (Targeted Therapy, Chemotherapy, Immunotherapy), By Disease Type, By Distribution Channel, By End User, Companies to 2034.

US$ 3,482.00

The global Oral Cancer Therapeutics Market size is forecast to increase from $2.3 Billion in 2026 to $3.35 Billion in 2034 at a CAGR of 4.8% between 2026 and 2034. The Oral Cancer Therapeutics market...

July 2026 190 pages

Pancreatic Cancer Market Size, Share and Growth Outlook 2026: By Type (Exocrine Pancreatic Cancer, Neuroendocrine Pancreatic Cancer), By Treatment Type, By End-User, Companies to 2034.

US$ 3,482.00

The global Pancreatic Cancer Market size is forecast to increase from $3.58 Billion in 2026 to $9.25 Billion in 2034 at a CAGR of 12.6% between 2026 and 2034. The Pancreatic Cancer market report provi...

July 2026 190 pages

PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size, Share and Growth Outlook 2026: By Drug Type (Olaparib, Niraparib, Rucaparib, Talazoparib), By Indication, By Patient Type, By End-User, Companies to 2034.

US$ 3,482.00

The global PARP (Poly ADP-ribose Polymerase) Inhibitors Market size is forecast to increase from $8.06 Billion in 2026 to $20.83 Billion in 2034 at a CAGR of 12.6% between 2026 and 2034. The PARP Inhi...

July 2026 190 pages

PD-1 and PD-L1 Inhibitors Market Size, Share and Growth Outlook 2026: By Type of Inhibitor (PD-1 Inhibitors, PD-L1 Inhibitors), By Cancer Type, By Distribution Channel, Companies to 2034.

US$ 3,482.00

The global PD-1 and PD-L1 Inhibitors Market size is forecast to increase from $70.53 Billion in 2026 to $202.61 Billion in 2034 at a CAGR of 14.1% between 2026 and 2034. The PD-1 and PD-L1 Inhibitors...

July 2026 190 pages

Pharyngeal Cancer Therapeutics Market Size, Share and Growth Outlook 2026: By Therapy Type, By Disease Type, By Route of Administration, By Distribution Channel, By End-User, Companies to 2034

US$ 3,482.00

The global Pharyngeal Cancer Therapeutics Market size is forecast to increase from $2.56 Billion in 2026 to $4.43 Billion in 2034 at a CAGR of 7.1% between 2026 and 2034. The Pharyngeal Cancer Therape...

July 2026 190 pages

Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size, Share and Growth Outlook 2026: By Application (Chronic Lymphocytic Leukemia, Follicular Lymphoma, Other Indications), By Distribution Channel, By End-User, Companies to 2034.

US$ 3,482.00

The global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market size is forecast to increase from $311.4 Million in 2026 to $485.2 Million in 2034 at a CAGR of 5.7% between 2026 and 2034. The Phosphoino...

July 2026 190 pages

Prostate Cancer Devices Market Size, Share and Growth Outlook 2026: By Product Type, By Deployment, By End User, Companies to 2034

US$ 3,482.00

The global Prostate Cancer Devices Market size is forecast to increase from $4.52 Billion in 2026 to $8.43 Billion in 2034 at a CAGR of 8.1% between 2026 and 2034. The Prostate Cancer Devices market r...

July 2026 190 pages

Proteasome Inhibitors Market Size, Share and Growth Outlook 2026: By Drug Type (Bortezomib, Carfilzomib, Ixazomib, Next-Generation / Emerging Inhibitors), By Route of Administration, By Indication, By Distribution Channel, Companies to 2034.

US$ 3,482.00

The global Proteasome Inhibitors Market size is forecast to increase from $10.57 Billion in 2026 to $20 Billion in 2034 at a CAGR of 8.3% between 2026 and 2034. The Proteasome Inhibitors market report...

July 2026 190 pages

Proton Therapy Market Size, Share and Growth Outlook 2026: By System (Single-Room Systems, Multi-Room Systems), By Indication, By End User, Companies to 2034.

US$ 3,482.00

The global Proton Therapy Market size is forecast to increase from $926.6 Million in 2026 to $1664.91 Million in 2034 at a CAGR of 7.6% between 2026 and 2034. The Proton Therapy market report provides...

July 2026 190 pages

Testicular Cancer Drugs Market Size, Share and Growth Outlook 2026: By Drug Class, By Histology Type, By Disease Stage, By Line of Therapy, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Testicular Cancer Drugs Market size is forecast to increase from $733.07 Million in 2026 to $935.87 Million in 2034 at a CAGR of 3.1% between 2026 and 2034. The Testicular Cancer Drugs mark...

July 2026 190 pages